1. Real workflow, not demo conditions
The pilot has been tested in the operating path people actually use: handoffs, exceptions, incomplete data, time pressure, and the systems that will remain after the pilot team leaves.
AI pilot evaluation
When is an AI pilot ready to scale?
A pilot is ready to scale when real-workflow evidence shows it creates enough value under the operating conditions you will actually face — not only that a model scored well in a sandbox.
For CAIO, CIO, CTO, clinical, operations, Responsible AI, and risk leaders deciding go / no-go / narrow / keep measuring.
GO
NO-GO
SCALE
NO-GO
SCALE
Direct answer
Scale when five conditions are true enough to defend.
If any one fails badly, the honest move is usually narrow, redesign, extend measurement, or stop — not a wider rollout.
2. Outcomes that matter to the business case
You can show clinical, operational, member/customer, or economic effects against pre-agreed success criteria — not only accuracy metrics that never appear in the budget conversation.
3. Value after leakage
Estimated realized value still looks positive after retained human handling, rework, delay, expected failure cost, and AI/control operating cost. Adoption without enterprise value is not a scale case.
4. Authority and oversight are defined
You know when the AI-shaped action may proceed, when verification or human review is required, who owns exceptions, and how the decision trail is preserved.
5. Scale does not invent a new product
Broader use needs named changes to workflow, integration, staffing, policy, monitoring, and controls — not hope that more volume will behave like the pilot cohort.
What “not ready” usually looks like
Sandbox-only results, success criteria written after the fact, no owner for failures, blanket human review that will not survive volume, or a business case that collapses once rework and delay are counted.
Decision options
Go, no-go, narrow, keep measuring, or change the control posture.
A useful pilot evaluation ends in an actionable recommendation leadership can defend — not a slide that says “promising.”
Scale
Expand with a concrete operating plan.
Evidence supports broader use, and the required workflow, integration, adoption, and control changes are named.
Narrow
Keep where it works.
Limit population, site, or decision class until the weak conditions are fixed.
Measure
Extend the proof plan.
The question is still evidentiary: more time, better labels, shadow mode, or a tighter success definition.
Control
Authority is the blocker.
Efficacy may be fine, but consequential actions need clearer proceed / verify / review / hold rules before scale. That is a Decision Control Assessment question, not another accuracy bake-off.
See how GNS-AI runs Pilot Efficacy & Scale Readiness · Healthcare & health plans · Federal & public sector
Next step
Have a pilot that looks promising but is hard to scale with confidence?
Bring it to a fit call. We will determine whether the next move is Prove, Control, redesign, or stop.